{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T20:07:14Z","timestamp":1762459634787,"version":"3.37.3"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2018,7,13]],"date-time":"2018-07-13T00:00:00Z","timestamp":1531440000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2018,7,13]],"date-time":"2018-07-13T00:00:00Z","timestamp":1531440000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["R01 MH095507","R01 MH098744"],"award-info":[{"award-number":["R01 MH095507","R01 MH098744"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1056051"],"award-info":[{"award-number":["OPP1056051"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000200","name":"United States Agency for International Development","doi-asserted-by":"publisher","award":["AID-OAA-A-12-00023"],"award-info":[{"award-number":["AID-OAA-A-12-00023"]}],"id":[{"id":"10.13039\/100000200","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AIDS Behav"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1007\/s10461-018-2221-3","type":"journal-article","created":{"date-parts":[[2018,7,13]],"date-time":"2018-07-13T08:21:41Z","timestamp":1531470101000},"page":"3718-3725","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Patterns of Oral PrEP Adherence and HIV Risk Among Eastern African Women in HIV Serodiscordant Partnerships"],"prefix":"10.1007","volume":"22","author":[{"name":"for the Partners Demonstration Project Team","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Pyra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth R.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica E.","family":"Haberer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renee","family":"Heffron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Connie","family":"Celum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth A.","family":"Bukusi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Asiimwe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elly","family":"Katabira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nelly R.","family":"Mugo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jared M.","family":"Baeten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,7,13]]},"reference":[{"unstructured":"AIDS by the Numbers. Geneva, Switzerland: UNAIDS; 2016. http:\/\/www.unaids.org\/sites\/default\/files\/media_asset\/AIDS-by-the-numbers-2016_en.pdf . Accessed 29 Nov 2017.","key":"2221_CR1"},{"unstructured":"Prevention Gap Report. Geneva, Switzerland: UNAIDS; 2016. http:\/\/www.unaids.org\/sites\/default\/files\/media_asset\/2016-prevention-gap-report_en.pdf . Accessed 29 Nov 2017.","key":"2221_CR2"},{"key":"2221_CR3","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1056\/NEJMoa1202614","volume":"367","author":"L Van Damme","year":"2012","unstructured":"Van Damme L, Corneli A, Ahmed K, Agot K, Lombaard J, Kapiga S, et al. Preexposure prophylaxis for HIV infection among African women. N Engl J Med. 2012;367:411\u201322.","journal-title":"N Engl J Med"},{"key":"2221_CR4","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1056\/NEJMoa1402269","volume":"372","author":"JM Marrazzo","year":"2015","unstructured":"Marrazzo JM, Ramjee G, Richardson BA, Gomez K, Mgodi N, Nair G, et al. Tenofovir-based preexposure prophylaxis for HIV infection among African women. N Engl J Med. 2015;372:509\u201318.","journal-title":"N Engl J Med"},{"issue":"4","key":"2221_CR5","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1097\/QAI.0000000000000880","volume":"71","author":"A Corneli","year":"2016","unstructured":"Corneli A, Perry B, McKenna K, Agot K, Ahmed K, Taylor J, et al. Participants\u2019 explanations for non-adherence in the FEM-PrEP clinical trial. J Acquir Immune Defic Syndr. 2016;71(4):452\u201361.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"2","key":"2221_CR6","doi-asserted-by":"publisher","first-page":"e89118","DOI":"10.1371\/journal.pone.0089118","volume":"9","author":"A van der Straten","year":"2014","unstructured":"van der Straten A, Stadler J, Montgomery E, Hartmann M, Magazi B, Mathebula F, et al. Women\u2019s experiences with oral and vaginal pre-exposure prophylaxis: the VOICE-C Qualitative Study in Johannesburg, South Africa. PLoS ONE. 2014;9(2):e89118.","journal-title":"PLoS ONE"},{"key":"2221_CR7","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1056\/NEJMoa1108524","volume":"367","author":"JM Baeten","year":"2012","unstructured":"Baeten JM, Donnell D, Ndase P, Mugo NR, Campbell JD, Wangisi J, et al. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med. 2012;367:399\u2013410.","journal-title":"N Engl J Med"},{"issue":"13","key":"2221_CR8","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1097\/QAD.0b013e3283629037","volume":"27","author":"PM Murnane","year":"2013","unstructured":"Murnane PM, Celum C, Mugo N, Campbell JD, Donnell D, Bukusi E, et al. Efficacy of pre-exposure prophylaxis for HIV-1 prevention among high risk heterosexuals: subgroup analyses from the Partners PrEP Study. AIDS Lond Engl. 2013;27(13):2155\u201360.","journal-title":"AIDS Lond Engl."},{"key":"2221_CR9","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1056\/NEJMoa1110711","volume":"367","author":"MC Thigpen","year":"2012","unstructured":"Thigpen MC, Kebaabetswe PM, Paxton LA, Smith DK, Rose CE, Segolodi TM, et al. Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. N Engl J Med. 2012;367:423\u201334.","journal-title":"N Engl J Med"},{"key":"2221_CR10","doi-asserted-by":"publisher","first-page":"e1002099","DOI":"10.1371\/journal.pmed.1002099","volume":"13","author":"JM Baeten","year":"2016","unstructured":"Baeten JM, Heffron R, Kidoguchi L, Mugo NR, Katabira E, Bukusi EA, et al. Integrated delivery of antiretroviral treatment and pre-exposure prophylaxis to HIV-1-serodiscordant couples: a prospective implementation study in Kenya and Uganda. PLoS Med. 2016;13:e1002099.","journal-title":"PLoS Med."},{"key":"2221_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(17)30156-X","author":"L-G Bekker","year":"2017","unstructured":"Bekker L-G, Roux S, Sebastien E, Yola N, Amico KR, Hughes JP, et al. Daily and non-daily pre-exposure prophylaxis in African women (HPTN 067\/ADAPT Cape Town Trial): a randomised, open-label, phase 2 trial. Lancet HIV. 2017. https:\/\/doi.org\/10.1016\/S2352-3018(17)30156-X .","journal-title":"Lancet HIV."},{"issue":"5","key":"2221_CR12","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1007\/s10461-016-1458-y","volume":"21","author":"KR Amico","year":"2017","unstructured":"Amico KR, Wallace M, Bekker L-G, Roux S, Atujuna M, Sebastian E, et al. Experiences with HPTN 067\/ADAPT study-provided open-label PrEP among women in Cape Town: facilitators and barriers within a mutuality framework. AIDS Behav. 2017;21(5):1361\u201375.","journal-title":"AIDS Behav"},{"issue":"1","key":"2221_CR13","doi-asserted-by":"publisher","first-page":"21134","DOI":"10.7448\/IAS.19.1.21134","volume":"19","author":"RC Patel","year":"2016","unstructured":"Patel RC, Stanford-Moore G, Odoyo J, Pyra M, Wakhungu I, Anand K, et al. \u201cSince both of us are using antiretrovirals, we have been supportive to each other\u201d: facilitators and barriers of pre-exposure prophylaxis use in heterosexual HIV discordant couples in Kisumu, Kenya. JIAS. 2016;19(1):21134.","journal-title":"JIAS."},{"key":"2221_CR14","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1097\/QAD.0000000000000647","volume":"29","author":"JE Haberer","year":"2015","unstructured":"Haberer JE, Bangsberg DR, Baeten JM, Curran K, Koechlin F, Amico KR, et al. Defining success with HIV pre-exposure prophylaxis: a prevention-effective adherence paradigm. AIDS. 2015;29:1277\u201385.","journal-title":"AIDS."},{"key":"2221_CR15","first-page":"1","volume":"20","author":"JE Haberer","year":"2017","unstructured":"Haberer JE, Kidoguchi L, Heffron R, Mugo N, Bukusi E, Katabira E, et al. Alignment of adherence and risk for HIV acquisition in a demonstration project of pre-exposure prophylaxis among HIV serodiscordant couples in Kenya and Uganda: a prospective analysis of prevention-effective adherence. J Int AIDS Soc. 2017;20:1\u20139.","journal-title":"J Int AIDS Soc."},{"key":"2221_CR16","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1097\/QAI.0b013e31827e622d","volume":"62","author":"EM Kahle","year":"2013","unstructured":"Kahle EM, Hughes JP, Lingappa JR, John-Stewart G, Celum C, Nakku-Joloba E, et al. An empiric risk scoring tool for identifying high-risk heterosexual HIV-1 serodiscordant couples for targeted HIV-1 prevention. J Acquir Immune Defic Syndr. 2013;62:339\u201347.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"2221_CR17","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1186\/s12879-016-1899-y","volume":"16","author":"EM Irungu","year":"2016","unstructured":"Irungu EM, Heffron R, Mugo N, Ngure K, Katabira E, Bulya N, et al. Use of a risk scoring tool to identify higher-risk HIV-1 serodiscordant couples for an antiretroviral-based HIV-1 prevention intervention. BMC Infect Dis. 2016;16(1):571.","journal-title":"BMC Infect Dis"},{"key":"2221_CR18","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/QAI.0b013e3181ca48bf","volume":"54","author":"TR Glass","year":"2010","unstructured":"Glass TR, Battegay M, Cavassini M, De Geest S, Furrer H, Vernazza PL, et al. Longitudinal analysis of patterns and predictors of changes in self-reported adherence to antiretroviral therapy: Swiss HIV Cohort Study. J Acquir Immune Defic Syndr. 2010;54:197\u2013203.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2221_CR19","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1097\/QAI.0000000000000101","volume":"65","author":"HA Pines","year":"2014","unstructured":"Pines HA, Gorbach PM, Weiss RE, Shoptaw S, Landovitz RJ, Javanbakht M, et al. Sexual risk trajectories among MSM in the United States: implications for pre-exposure prophylaxis delivery. J Acquir Immune Defic Syndr. 2014;65:579\u201386.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2221_CR20","doi-asserted-by":"publisher","DOI":"10.4159\/9780674041318","volume-title":"Group-based modeling of development","author":"DS Nagin","year":"2005","unstructured":"Nagin DS. Group-based modeling of development. Cambridge: Harvard University Press; 2005."},{"unstructured":"Jones BL. traj: group-based modeling of longitudinal data. Traj Group-Based Model Longitud Data. https:\/\/www.andrew.cmu.edu\/user\/bjones\/index.htm . Accessed 25 Apr 2018.","key":"2221_CR21"},{"key":"2221_CR22","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1177\/0049124106292364","volume":"35","author":"BL Jones","year":"2007","unstructured":"Jones BL, Nagin DS. Advances in group-based trajectory modeling and an SAS procedure for estimating them. Sociol Methods Res. 2007;35:542\u201371.","journal-title":"Sociol Methods Res."},{"key":"2221_CR23","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1111\/j.1745-9125.2005.00026.x","volume":"43","author":"DS Nagin","year":"2005","unstructured":"Nagin DS, Tremblay RE. Developmental trajectory groups: fact or a useful statistical fiction?*. Criminology. 2005;43:873\u2013904.","journal-title":"Criminology."},{"key":"2221_CR24","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1146\/annurev.clinpsy.121208.131413","volume":"6","author":"DS Nagin","year":"2010","unstructured":"Nagin DS, Odgers CL. Group-based trajectory modeling in clinical research. Annu Rev Clin Psychol. 2010;6:109\u201338.","journal-title":"Annu Rev Clin Psychol."},{"key":"2221_CR25","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1177\/0049124101029003005","volume":"29","author":"BL Jones","year":"2001","unstructured":"Jones BL, Nagin DS, Roeder K. A SAS procedure based on mixture models for estimating developmental trajectories. Sociol Methods Res. 2001;29:374\u201393.","journal-title":"Sociol Methods Res."},{"doi-asserted-by":"crossref","unstructured":"Blumenthal J, Jain S, Dube M, Sun X, Ellorin E, Hoenigl M, et al. Recent HIV Risk Behavior and Partnership Type predict PrEP adherence in men who have sex with men. San Diego, CA; 2017. https:\/\/idsa.confex.com\/idsa\/2017\/viewsessionpdf.cgi . Accessed 8 Dec 2017.","key":"2221_CR26","DOI":"10.1093\/ofid\/ofx162.038"},{"key":"2221_CR27","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1007\/s10461-011-0003-2","volume":"16","author":"LE Napper","year":"2012","unstructured":"Napper LE, Fisher DG, Reynolds GL. Development of the perceived risk of HIV scale. AIDS Behav. 2012;16:1075\u201383.","journal-title":"AIDS Behav"},{"key":"2221_CR28","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1080\/09540121.2010.543880","volume":"23","author":"H Bradley","year":"2011","unstructured":"Bradley H, Tsui A, Hindin M, Kidanu A, Gillespie D. Developing scales to measure perceived HIV risk and vulnerability among Ethiopian women testing for HIV. AIDS Care. 2011;23:1043\u201352.","journal-title":"AIDS Care."},{"key":"2221_CR29","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1097\/OLQ.0000000000000472","volume":"43","author":"JJ Carroll","year":"2016","unstructured":"Carroll JJ, Heffron R, Mugo N, Ngure K, Ndase P, Asiimwe S, et al. Perceived risk among human immunodeficiency virus serodiscordant couples in East Africa taking oral pre-exposure prophylaxis. Sex Transm Dis. 2016;43:471\u20135.","journal-title":"Sex Transm Dis"},{"key":"2221_CR30","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1097\/QAI.0000000000000172","volume":"66","author":"D Donnell","year":"2014","unstructured":"Donnell D, Baeten JM, Bumpus NN, Brantley J, Bangsberg DR, Haberer JE, et al. HIV protective efficacy and correlates of tenofovir blood concentrations in a clinical trial of PrEP for HIV prevention. J Acquir Immune Defic Syndr. 2014;66:340\u20138.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"7","key":"2221_CR31","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1097\/QAD.0000000000001024","volume":"30","author":"N Musinguzi","year":"2016","unstructured":"Musinguzi N, Muganzi CD, Boum Y, Ronald A, Marzinke MA, Hendrix CW, et al. Comparison of subjective and objective adherence measures for pre-exposure prophylaxis against HIV infection among serodiscordant couples in East Africa. AIDS Lond Engl. 2016;30(7):1121.","journal-title":"AIDS Lond Engl."},{"key":"2221_CR32","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1016\/S1473-3099(13)70226-3","volume":"13","author":"KK Mugwanya","year":"2013","unstructured":"Mugwanya KK, Donnell D, Celum C, Thomas KK, Ndase P, Mugo N, et al. Sexual behavior of heterosexual men and women receiving antiretroviral pre-exposure prophylaxis for HIV prevention: a longitudinal analysis. Lancet Infect Dis. 2013;13:1021\u20138.","journal-title":"Lancet Infect Dis."}],"container-title":["AIDS and Behavior"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10461-018-2221-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-018-2221-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-018-2221-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,27]],"date-time":"2022-08-27T13:32:07Z","timestamp":1661607127000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10461-018-2221-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,13]]},"references-count":32,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["2221"],"URL":"https:\/\/doi.org\/10.1007\/s10461-018-2221-3","relation":{},"ISSN":["1090-7165","1573-3254"],"issn-type":[{"type":"print","value":"1090-7165"},{"type":"electronic","value":"1573-3254"}],"subject":[],"published":{"date-parts":[[2018,7,13]]},"assertion":[{"value":"13 July 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"JMB has led studies with pre-exposure prophylaxis medication donated by Gilead Sciences and served on an advisory committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The University of Washington Human Subjects Division and ethics review committees at each site (the National HIV\/AIDS Research Committee of the Uganda National Council for Science and Technology or the Ethics Review Committee of the Kenya Medical Research Institute) approved the protocol. All participants provided written informed consent in their preferred language in accordance with the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval and Informed Consent"}}]}}